A10AE06 - Insulin Degludec |
Not porphyrinogenic |
NP |
Rationale
Insulin degludec has no porphyrinogenic effects.
Chemical description
Antidiabetic pancreatic hormone consisting of polypeptide chains, connected by disulfide bridges.
Metabolism and pharmakokinetics
Insulin degludec is a basal insulin that forms soluble multi-hexamers upon subcutaneous injection, which are slowly and continuously absorbed into the bloodstream leading to a flat and stable glucose-lowering-effect.
Degradation of insulin degludec is similar to that of human insulin; all metabolites formed are inactive.
References
- Scientific articles
- Muñoz Torres M. Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: advances in clinical research. Endocrinol Nutr. 2014 Mar;61(3):153-9. PMID 23890782. #3191
- Summary of Product Characteristics
- The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Tresiba. #3192
Similar drugs
© NAPOS 2024